We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02934464
Brief Title: Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)

First Submitted : October 6, 2016
First Submitted that Met QC Criteria : October 13, 2016
First Posted : October 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 3, 2021
Last Update Posted : September 13, 2021